Interleukin 20 (IL-20) is a pleotropic IL-10 family cytokine that protects epithelial surfaces from pathogens. However, dysregulated IL-20 signaling is implicated in several human pathologies including psoriasis, rheumatoid arthritis, atherosclerosis, and osteoporosis. IL-20, and related cytokines IL-19 and IL-24, designated IL-20 subfamily cytokines (IL-20SFCs), induce cellular responses through an IL-20R1/IL-20R2 (type I) receptor heterodimer, whereas IL-20 and IL-24 also signal through the IL-22R1/IL-20R2 (type II) receptor complex. The crystal structure of the IL-20/IL-20R1/IL-20R2 complex reveals how type I and II complexes discriminate cognate from noncognate ligands. The structure also defines how the receptor-cytokine interfaces are affinity tuned to allow distinct signaling through a receptor complex shared by three different ligands. Our results provide unique insights into the complexity of IL-20SFC signaling that may be critical in the design of mechanistic-based inhibitors of IL-20SFC-mediated inflammatory disease.
IL-20 SFCs induce cellular signaling through a common receptor heterodimer composed of IL-20R1 and IL-20R2 chains (type I complex) ( Fig. 1) (1, 6, 7) . IL-20 and IL-24 also signal through an IL-22R1/IL-20R2 heterodimer (type II complex), whereas IL-19 only signals through the type I complex (6, 7) . IL-20R1 and IL-22R1 also pair with the IL-10R2 chain to form receptor heterodimers that induce cell signaling upon IL-26 (IL-20R1/IL-10R2) and IL-22 (IL-22R1/IL-10R2) binding, respectively (8) (9) (10) . Despite promiscuous pairing of the R2 chains, IL-20R2 cannot substitute for IL-10R2 in IL-22 signaling (6) . Furthermore, IL-19, IL-20, and IL-24 appear to have largely nonredundant biological activities in vivo, suggesting they may engage type I and type II receptor heterodimers differently (6, 7, 11) . However, a mechanistic basis for such differences has not been determined.
IL-20 has been implicated in the pathophysiology of psoriasis (1). Transgenic (Tg) mice overexpressing IL-20 exhibit a phenotype similar to human psoriatic skin, and IL-20 neutralizing antibodies resolve psoriasis in a human xenograft transplation model (1, 12) . Increased levels of IL-19 and IL-24 are also observed in skin samples from psoriasis patients, but the significance and/or biological function of IL-19 and IL-24 is less clear (3) . IL-24 Tg mice exhibit epidermal hyperplasia and proliferation, suggesting IL-24 activity in vivo is similar to IL-20 (13) . However, IL-19 Tg mice were reported to exhibit a normal skin phenotype, which is consistent with IL-19's unique receptor specificity. IL-20 is also implicated in rheumatoid arthritis (RA) (14) and atherosclerosis (15) . IL-20 also exhibits arteriogenic/angiogenic properties and may be important for treating ischemic disease (16) .
Most recently, IL-20 was found to induce osteoclastogenesis, by up-regulating the receptor activator of NFκB (RANK)-RANK ligand signaling proteins and may be a therapeutic target for osteoporosis (17) .
Expression of the IL-20R1/IL-20R2 and IL-22R1/IL-20R2 heterodimers, which are required for IL-20 bioactivity, have been observed only on cells of epithelial origin including skin, lung, and testis (1, 18, 19) . These data suggest a major role for IL-20 SFCs in mediating cross-talk between infiltrating immune cells (T cells, macrophages, and dendritic cells) that express the IL20SFCs, and the skin. However, in some cases the pleotropic activities of IL-20 are at odds with the cellular expression of the IL-20 receptors. In particular, IL-20 and IL-19 induce naïve T cells toward a TH2 secretory phenotype, characterized by increased IL-4, IL-13, and reduced IFNγ production (20, 21) . However, only IL-20R2 but not IL-20R1 or IL-22R1 have been detected in immune cells (1, 18, 19) . In addition, IL-20R2 knockout mice exhibit disrupted CD4
+ and CD8 + T-cell function (22) , which implicates the IL-20 SFCs in T-cell signaling, despite the absence of the IL-20R1 and IL-22R1 receptor chains on these cells (18) . On the basis of these data, it has been hypothesized that another receptor chain must pair with IL-20R2 to induce IL-20SFC signaling on immune cells.
IL-20 has emerged as a highly pleotropic cytokine involved in essential cellular processes and pathology. Despite an improved understanding of IL-20 biology, the molecular mechanisms that allow IL-20, IL-19, and IL-24 to discriminate and activate type I (IL-20R1/IL-20R2) and type II (IL-22R1/IL-20R2) receptor complexes are currently unknown. To address this question, we have determined the crystal structure of the IL-20/IL-20R1/IL-20R2 complex to determine how signaling complexity can be obtained for structurally similar cytokines. The structure of IL-20/IL-20R1/IL-20R2 ( Fig. 2A ) was solved at 2.8Ǻ by single wavelength anomalous diffraction phasing and molecular replacement methods (Table S1 ). IL-20 adopts an α-helical fold, which is highly conserved with IL-19 (rmsd 0.79Ǻ). Despite structurally similar helical cores, the N terminus of IL-20 adopts a novel β-hairpin structure, rather than the 3 10 helix/coil structure observed in IL-19 ( This article is a PNAS Direct Submission. 1 To whom correspondence should be addressed. E-mail: walter@uab.edu.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. 1073/pnas.1117551109/-/DCSupplemental. Fig. S1 ). Thus, the predicted structural similarity of IL-20 and IL-24 is consistent with the identical receptor binding profiles of each cytokine (Fig. 1) .
Methods,
The extracellular fragments of IL-20R1 and IL-20R2 each consist of tandem β-sandwich domains (D1 and D2) that assemble around IL-20 to form a V-shaped complex, when viewed down the α-helical bundle axis of IL-20 ( Fig. 2A) . X-ray analysis of IL-20R1 and IL-20R2 completes the structural descriptions of all five IL-10 family receptors (23) (24) (25) (26) (Fig. 1) . Structural comparisons of the receptors reveal the three R1 chains are highly similar to one another, whereas IL-10R2 and IL-20R2 exhibit structurally divergent cytokine binding loops and interdomain angles ( (1,576Ǻ 2 ) consists of two contact surfaces, site 1a and site 1b (Fig. 3A) . Site 1a is formed by IL-20R1 L2-L4 loops that contact a small cavity on IL-20 located at the intersection of helix F and AB loop. Site 1b contacts occur between IL-20R1 L6 and the N terminus of helix A. Site 1a contributes ∼83% of the total buried surface area and eight of nine hydrogen bond (H-bond)/salt bridge interactions identified in the IL-20/IL-20R1 interface (Table S2 and , whereas residues on L4 and L5 loops form hydrogen bonds with helix A and the IL-20 N terminus. As observed in site 1a, the IL-20R2 L2 loop forms the majority of contacts in site 2 by contributing 57% of the buried surface area, and 9 of 13 hydrogen bonds in the IL-20/IL-20R2 interface (Table S3) Essentially all contacts between IL-20 and the receptors are mediated by the D1 domains, whereas IL-20R1 and IL-20R2 D2 domains contact one another to form the base of the Vshaped complex (site 3, Figs. 2A and 5A). The site 3 interface (1,036Ǻ 2 ) is formed from IL-20R1 D2 residues on β-strand C′, the CC′ loop, and the EF loop, which contact IL-20R2 residues on the AB loop, β-strand E, and the EF loop. The interface is quite extensive, including 6 hydrogen bonds (Table S4) 2 of accessible surface area. Two IL-20R1 chains are also in the complex, but they do not contribute residues to the dimer interface. Although the formation of cell surface IL-20R2 dimers might provide an explanation for IL-20SFC signaling on immune cells that apparently lack IL-20R1 (27), we have been unable to detect an IL-19/IL-20R2 dimeric complex in solution or identify significant differences in IL-20SFC binding affinity between monomeric and dimeric IL-20R2 (SI Materials and Methods, Fig. S4 and Table S6 ).
Mechanisms Regulating IL-20R1 Chain Affinity. Surface plasmon resonance (SPR) experiments were performed to quantify IL-20R1 binding to IL-19 and IL-20 (Fig. 6 ). We could not detect binding between IL-19 and IL-20R1 at IL-19 concentrations up to 10 μM. However, a binding constant of ∼9 μM was determined for the IL-20/IL-20R1 interaction (Fig. 6B) . In contrast to very weak IL-20R1 interactions, IL-10R1 and IL-22R1 chains exhibit ∼10,000-fold tighter binding affinity for IL-10 (kDa = 0.5 nM) and IL-22 (kDa = 1.2 nM) (24, 28) (Fig. 1 ). These extremely different binding affinities occur despite structurally similar IL-20/IL-20R1, IL-22/IL-22R1, and IL-10/IL-10R1 binary complexes (Fig. 3B) . Comparison of each interface reveals identical "YG" interaction motifs consisting of receptor YG residues (L2 loop Tyr-76 sIL-20R1 and Gly-77 sIL-20R1 in IL-20R1, Fig. 3A ) that are inserted into a conserved cleft formed by the AB loop and helix F of the ligands (Fig. 3 C and D) (23, 24, 26) . Buried surface area does not predict the observed affinities of the different complexes (Table S7) . However, complex affinities correlate with unique contacts made by four receptor residues (D1 residues Phe-74 (L2 loop), Glu-105 (L3 loop), Tyr-109, and Arg-128 (L4 loop) in IL-20R1, Fig. 3 C and D; for clarity, IL-20R1 numbering will be used throughout the text), located adjacent to the YG interaction motif (Fig. 3 C and D) .
In the high-affinity IL-10/IL-10R1 complex, Arg-109
and Arg-128 IL-10R1 , adjacent to the YG motif, form a network of four hydrogen bonds with IL-10 residues Gln-38 IL-10 and Asp-166 IL-10 ( Fig. 3C) . However, in IL-20/20R1 and IL-22/IL-22R1 3D) . Thus, this network of four hydrogen bonds in the IL-10/IL-10R1 interface is reduced to one in IL-20/IL-20R1 and IL-22/IL-22R1 interfaces.
To compensate for the loss of an "IL-10 like" bonding network, the IL-22/IL-22R1 interface forms a unique three hydrogen bond network on the opposite side of the YG motif (Fig.  3D) (26) .
Consistent with its low affinity and in contrast to IL-10/IL-10R1 and IL-22/IL-22R1, the IL-20/IL-20R1 complex does not form additional site 1a hydrogen bonding networks (Fig. 3D) . (Fig. 6 C and D) . The structural differences between IL-19 and IL-20 demonstrate helix C and the CD loop are conformationally dynamic, which may also influence IL-20R2 binding affinity.
Structural Mechanisms Regulating Cognate vs. Noncognate Ligand
Specificity. IL-20R1 and IL-22R1 form promiscuous interactions with five different cytokines and two R2 chains to engage different signaling responses that protect the host from invading pathogens (Fig. 1) . These cognate ligand receptor complexes have been "affinity tuned," using mechanisms described above, to optimize their signaling properties. However, IL-19 cannot bind or signal through the IL-22R1 chain. Furthermore, IL-22 cannot bind or induce signaling through the IL-20R1 chain (Fig.   1) . Superposition of IL-22 onto IL-20/IL-20R1 reveals the major specificity determinant is site 1b, where the IL-20R1 L6 loop forms steric clashes with IL-22 helix A residues Phe-57 IL22 and Asn-54 (Fig. 3F) . Similar clashes are observed between IL-22R1 L6 and the N terminus of IL-19 (Fig. 3E) , which explains why IL-19 cannot signal through the type II complex (Fig. 1) . Thus, although cognate site 1b contacts are not always extensive, they are clearly critical in determining ligand-receptor specificity. These results provide additional evidence for a two-point (site 1a/site 1b) R1 chain specificity mechanism described by Jones et al. (24) .
Signaling specificity is also achieved through the IL-20R2 chain, which must engage IL-19, IL-20, and IL-24, but prevent IL-22 signaling through the type II (IL-22R1/IL-20R2) complex (Fig. 1 (Fig. 6 E-H) suggest the IL-20 type I complex (Fig. 1) is the most stable complex with apparent equilibrium dissociation constant To further test the importance of the site 3 interface, three IL-20R1 site 3 residues that form site 3 contacts (Fig. 5A, ) were mutated to alanine to create an IL-20R1 triple mutant, M3. Coinjection of IL-19+M3 over an IL-20R2 biacore surface, generated the same binding response as IL-19 alone (Fig. 5B) . Coinjection of IL-20+ M3 exhibited an increased binding response, relative to IL-20 alone, although it was drastically reduced from the injection of IL-20+IL-20R1. The increased binding observed for the IL-20+ M3 injection corresponds to IL-20/M3 binary complexes binding to IL-20R2 with the same kinetics as the IL-20/IL-20R2 interaction (e.g., without the site 3 interaction). This result confirms the higher affinity of the IL-20/IL-20R1 site 1 interface (Fig. 6 A and B) , relative to IL-19/IL-20R1, and the importance of site 3 in forming stable ternary complexes essential for signal transduction.
The essential role of the site 3 interface in IL-20 ternary complex formation, led us to examine how the IL-20R1/IL-20R2 D2/D2 interface (site 3) differed from other cytokine ternary complexes. To ask this question, the D2 domains of growth hormone receptor (GHR, site 1) (29) and IL-6R (30) were superimposed onto IL-20R1 D2 and the orientations of GHR (site 2) and GP130 D2 domains were evaluated (Fig. 5C) . The GHR/GHR D2 domains are essentially parallel to one another and were assigned a D2-D2 crossing angle of 0°. Compared with GHRs, the D2 domains of IL-20R1/IL-20R2 and IL-6R/GP130 D2 cross at angles of −40°and +25°, respectively (Fig. 5C ). These differences may be important as the D2 domains are located adjacent to the membrane where they could selectively influence intracellular signal transduction pathways and ultimately cellular responses.
Not only is the IL-20/IL-20R1/IL-20R2 complex distinct from the distantly related class-1 cytokine complexes, but it is also distinct from IL-10R2-containing complexes (Fig. 1) . For example, superposition of the IL-22/IL-22R1 binary complex and IL-10R2 onto IL-20/IL-20R1/IL-20R2 results in a IL-22/IL-22R1/IL-10R2 complex that does not form a site 3 interface (Fig. 5D ). This result is caused by the distinct interdomain angle of IL-20R2 compared with IL-10R2 (SI Materials and Methods and Fig. S2 ). To determine whether IL-10R2 adopts a different interdomain angle in solution, compared with the crystal structure (25) , solution small angle X-ray scattering (SAXS) was performed on IL-10R2. These experiments confirm that IL-10R2 in solution adopts the same D1/D2 interdomain angle observed in the crystal structure (Fig. S6) . These studies further underscore the unique architectures of the IL-20R2 and IL-10R2 ternary complexes and their distinct assembly properties.
Discussion
The crystal structure of IL-20/IL-20R1/IL-20R2 depicts a complete signaling complex of an IL-10 family cytokine, although two binary complexes (IL-10/IL-10R1 and IL-22/IL-22R1) have been determined (23, 24, 26) . The surprising structural differences between IL-19 and IL-20 at the N-and C termini (SI Materials and Methods and Fig. S1 ) explains how structurally similar cytokines discriminate, via IL-20R1 and IL-22R1, between the type I and type II receptor heterodimers (Fig. 4 E and F) . In contrast, IL-22, which binds tightly to IL-22R1 (24), cannot signal through the type II complex due to steric clashes between IL-22/IL-20R2 in site 2, especially with Phe-105 IL22 (Fig. 5E) . These results provide a structural basis for IL-20SFC receptor specificity, which contributes to their distinct in vivo biological properties.
In addition to discriminating between the type I and type II complexes (Fig. 1) , IL-19 and IL-20 modulate their biological activities through distinct affinities for IL-20R1 and IL-20R2 chains (Fig. 6 ). Our structural studies now provide a molecular basis for how subtle structural rearrangements of the receptor interfaces, combined with amino acid substitutions, alter ligand receptor binding affinity. Prior experiments revealed IL-20R2 binds tighter to IL-19 and IL-20 than IL-20R1 (7, 31) . However, in contrast to ∼1 nM IL-10/IL-10R1 and IL-22/IL-22R1 affinities (Table S7) , IL-19/IL-20R2 and IL-20/IL-20R2 interactions are at least ∼100-fold weaker. Thus, in contrast to IL-10/IL-10R1 and IL-22/IL-22R1 complexes (Fig. 1) , the IL-20R2 chain does not dominate ligand binding energetics, but must rely on cooperation between IL-20R1 and IL-20R2 to assemble the signaling complex. This property may allow the type-I receptor heterodimer (Fig. 1) to selectively discriminate IL-19, IL-20, and IL-24 affinity differences and induce distinct cellular responses. Using SPR (Fig. 6) , the stability of the IL-20 type-I and type-II complexes were found to be more stable than the IL-19 type-I complex (Figs. 1 and 6 ). The molecular stabilities of the ternary complexes (IL-20 > IL-19) are consistent with robust IL-20 signaling in keratinocytes and its putative role in psoriasis, properties not shared by IL-19 (1, 7) .
The presence of an IL-20/IL-20R1/IL-20R2 dimer in the crystals (Fig. 2D) Table S6. individual proteins were incubated at approximately a 1:1:1 stoichiometric ratio and purified by gel filtration chromatography. Fractions containing the ternary complex were concentrated to 7 mg/mL for crystallization.
Crystallization, X-ray data collection and refinement, surface plasmon resonance, and SAXS experiments are described in SI Materials and Methods.
